Global Inactivated Polio Virus Vaccine Market Research Report 2024

Report ID: 1861454 | Published Date: Oct 2024 | No. of Page: 60 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Type I
        1.2.3 Type II
        1.2.4 Type III
    1.3 Market by Application
        1.3.1 Global Inactivated Polio Virus Vaccine Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Inactivated Polio Virus Vaccine Market Perspective (2017-2028)
    2.2 Inactivated Polio Virus Vaccine Growth Trends by Region
        2.2.1 Inactivated Polio Virus Vaccine Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Inactivated Polio Virus Vaccine Historic Market Size by Region (2017-2022)
        2.2.3 Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2023-2028)
    2.3 Inactivated Polio Virus Vaccine Market Dynamics
        2.3.1 Inactivated Polio Virus Vaccine Industry Trends
        2.3.2 Inactivated Polio Virus Vaccine Market Drivers
        2.3.3 Inactivated Polio Virus Vaccine Market Challenges
        2.3.4 Inactivated Polio Virus Vaccine Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue
        3.1.1 Global Top Inactivated Polio Virus Vaccine Players by Revenue (2017-2022)
        3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2017-2022)
    3.2 Global Inactivated Polio Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Inactivated Polio Virus Vaccine Revenue
    3.4 Global Inactivated Polio Virus Vaccine Market Concentration Ratio
        3.4.1 Global Inactivated Polio Virus Vaccine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Inactivated Polio Virus Vaccine Revenue in 2021
    3.5 Inactivated Polio Virus Vaccine Key Players Head office and Area Served
    3.6 Key Players Inactivated Polio Virus Vaccine Product Solution and Service
    3.7 Date of Enter into Inactivated Polio Virus Vaccine Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Polio Virus Vaccine Breakdown Data by Type
    4.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Type (2017-2022)
    4.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2023-2028)
5 Inactivated Polio Virus Vaccine Breakdown Data by Application
    5.1 Global Inactivated Polio Virus Vaccine Historic Market Size by Application (2017-2022)
    5.2 Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Inactivated Polio Virus Vaccine Market Size (2017-2028)
    6.2 North America Inactivated Polio Virus Vaccine Market Size by Country (2017-2022)
    6.3 North America Inactivated Polio Virus Vaccine Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Inactivated Polio Virus Vaccine Market Size (2017-2028)
    7.2 Europe Inactivated Polio Virus Vaccine Market Size by Country (2017-2022)
    7.3 Europe Inactivated Polio Virus Vaccine Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Inactivated Polio Virus Vaccine Market Size (2017-2028)
    8.2 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Country (2017-2022)
    8.3 Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Inactivated Polio Virus Vaccine Market Size (2017-2028)
    9.2 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2017-2022)
    9.3 Latin America Inactivated Polio Virus Vaccine Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Inactivated Polio Virus Vaccine Market Size (2017-2028)
    10.2 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2017-2022)
    10.3 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Detail
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Inactivated Polio Virus Vaccine Introduction
        11.1.4 Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2017-2022)
        11.1.5 Sanofi Recent Development
    11.2 GSK
        11.2.1 GSK Company Detail
        11.2.2 GSK Business Overview
        11.2.3 GSK Inactivated Polio Virus Vaccine Introduction
        11.2.4 GSK Revenue in Inactivated Polio Virus Vaccine Business (2017-2022)
        11.2.5 GSK Recent Development
    11.3 Serum Institute (Bilthoven Biologicals)
        11.3.1 Serum Institute (Bilthoven Biologicals) Company Detail
        11.3.2 Serum Institute (Bilthoven Biologicals) Business Overview
        11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Introduction
        11.3.4 Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2017-2022)
        11.3.5 Serum Institute (Bilthoven Biologicals) Recent Development
    11.4 IMBCA
        11.4.1 IMBCA Company Detail
        11.4.2 IMBCA Business Overview
        11.4.3 IMBCA Inactivated Polio Virus Vaccine Introduction
        11.4.4 IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2017-2022)
        11.4.5 IMBCA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Inactivated Polio Virus Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Type I
    Table 3. Key Players of Type II
    Table 4. Key Players of Type III
    Table 5. Global Inactivated Polio Virus Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Inactivated Polio Virus Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Inactivated Polio Virus Vaccine Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Inactivated Polio Virus Vaccine Market Share by Region (2017-2022)
    Table 9. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Inactivated Polio Virus Vaccine Market Share by Region (2023-2028)
    Table 11. Inactivated Polio Virus Vaccine Market Trends
    Table 12. Inactivated Polio Virus Vaccine Market Drivers
    Table 13. Inactivated Polio Virus Vaccine Market Challenges
    Table 14. Inactivated Polio Virus Vaccine Market Restraints
    Table 15. Global Inactivated Polio Virus Vaccine Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Inactivated Polio Virus Vaccine Market Share by Players (2017-2022)
    Table 17. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2021)
    Table 18. Ranking of Global Top Inactivated Polio Virus Vaccine Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Inactivated Polio Virus Vaccine Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Inactivated Polio Virus Vaccine Product Solution and Service
    Table 22. Date of Enter into Inactivated Polio Virus Vaccine Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Inactivated Polio Virus Vaccine Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2017-2022)
    Table 26. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Inactivated Polio Virus Vaccine Revenue Market Share by Type (2023-2028)
    Table 28. Global Inactivated Polio Virus Vaccine Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Inactivated Polio Virus Vaccine Revenue Market Share by Application (2017-2022)
    Table 30. Global Inactivated Polio Virus Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Inactivated Polio Virus Vaccine Revenue Market Share by Application (2023-2028)
    Table 32. North America Inactivated Polio Virus Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Inactivated Polio Virus Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Inactivated Polio Virus Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Inactivated Polio Virus Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Inactivated Polio Virus Vaccine Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Inactivated Polio Virus Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Inactivated Polio Virus Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Sanofi Company Detail
    Table 43. Sanofi Business Overview
    Table 44. Sanofi Inactivated Polio Virus Vaccine Product
    Table 45. Sanofi Revenue in Inactivated Polio Virus Vaccine Business (2017-2022) & (US$ Million)
    Table 46. Sanofi Recent Development
    Table 47. GSK Company Detail
    Table 48. GSK Business Overview
    Table 49. GSK Inactivated Polio Virus Vaccine Product
    Table 50. GSK Revenue in Inactivated Polio Virus Vaccine Business (2017-2022) & (US$ Million)
    Table 51. GSK Recent Development
    Table 52. Serum Institute (Bilthoven Biologicals) Company Detail
    Table 53. Serum Institute (Bilthoven Biologicals) Business Overview
    Table 54. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product
    Table 55. Serum Institute (Bilthoven Biologicals) Revenue in Inactivated Polio Virus Vaccine Business (2017-2022) & (US$ Million)
    Table 56. Serum Institute (Bilthoven Biologicals) Recent Development
    Table 57. IMBCA Company Detail
    Table 58. IMBCA Business Overview
    Table 59. IMBCA Inactivated Polio Virus Vaccine Product
    Table 60. IMBCA Revenue in Inactivated Polio Virus Vaccine Business (2017-2022) & (US$ Million)
    Table 61. IMBCA Recent Development
    Table 62. Research Programs/Design for This Report
    Table 63. Key Data Information from Secondary Sources
    Table 64. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Inactivated Polio Virus Vaccine Market Share by Type: 2021 VS 2028
    Figure 2. Type I Features
    Figure 3. Type II Features
    Figure 4. Type III Features
    Figure 5. Global Inactivated Polio Virus Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Inactivated Polio Virus Vaccine Report Years Considered
    Figure 9. Global Inactivated Polio Virus Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Inactivated Polio Virus Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Inactivated Polio Virus Vaccine Market Share by Region: 2021 VS 2028
    Figure 12. Global Inactivated Polio Virus Vaccine Market Share by Players in 2021
    Figure 13. Global Top Inactivated Polio Virus Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Virus Vaccine as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Inactivated Polio Virus Vaccine Revenue in 2021
    Figure 15. North America Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Inactivated Polio Virus Vaccine Market Share by Country (2017-2028)
    Figure 17. United States Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Inactivated Polio Virus Vaccine Market Share by Country (2017-2028)
    Figure 21. Germany Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Inactivated Polio Virus Vaccine Market Share by Region (2017-2028)
    Figure 29. China Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Inactivated Polio Virus Vaccine Market Share by Country (2017-2028)
    Figure 37. Mexico Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Inactivated Polio Virus Vaccine Market Share by Country (2017-2028)
    Figure 41. Turkey Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Inactivated Polio Virus Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Sanofi Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2017-2022)
    Figure 44. GSK Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2017-2022)
    Figure 45. Serum Institute (Bilthoven Biologicals) Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2017-2022)
    Figure 46. IMBCA Revenue Growth Rate in Inactivated Polio Virus Vaccine Business (2017-2022)
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Frequently Asked Questions
Inactivated Polio Virus Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inactivated Polio Virus Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inactivated Polio Virus Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports